Matinas biopharma appoints thomas hoover, m.b.a. as chief business officer

Bedminster, n.j., dec. 06, 2021 (globe newswire) -- matinas biopharma holdings, inc. (nyse amer: mtnb), a clinical-stage biopharmaceutical company focused on improving the intracellular delivery of critical therapeutics through its paradigm-changing lipid nanocrystal (lnc) platform delivery technology, today announced the appointment of thomas hoover to the newly created position of chief business officer.
MTNB Ratings Summary
MTNB Quant Ranking